コンテンツへスキップ
Merck
  • Protocol for generating in vitro glioma models using human-induced pluripotent- or embryonic-stem-cell-derived cerebral organoids.

Protocol for generating in vitro glioma models using human-induced pluripotent- or embryonic-stem-cell-derived cerebral organoids.

STAR protocols (2023-07-08)
Yilin Feng, Honghui Zheng, Jiyuan Tang, Xing Li, Ruilin Tian, Shaohua Ma
要旨

In glioma modeling, existing organoid protocols lack the ability to replicate glioma cell invasion and interaction with normal brain tissue. Here, we present a protocol for generating in vitro brain disease models using human-induced pluripotent- or embryonic-stem-cell-derived cerebral organoids (COs). We describe steps for forming glioma organoids by co-culturing forebrain organoids with U-87 MG cells. We also detail vibratome sectioning of COs to prevent cell death and enhance contact between U-87 MG cells and cerebral tissues.

材料
製品番号
ブランド
製品内容

Sigma-Aldrich
(−)-アデノシン3′5′-サイクリック一リン酸, ≥98.5% (HPLC), powder
Sigma-Aldrich
Anti-Brn-2 (POU3F2) Antibody, clone 8C4.2, clone 8C4.2, from mouse